State of Wisconsin Investment Board’s CG Oncology CGON Stock Holding History

State of Wisconsin Investment Board’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.82M	Sell	26,840 -486	-2%	-$27.5K	﹤0.01%	1436
2025 Q4	$1.13M	Buy	27,326 +14,139	+107%	+$585K	﹤0.01%	1624
2025 Q3	$531K	Sell	13,187 -443	-3%	-$12.9K	﹤0.01%	1861
2025 Q2	$354K	Sell	13,630 -337	-2%	-$8.12K	﹤0.01%	2001
2025 Q1	$342K	Buy	13,967 +3,074	+28%	+$86.5K	﹤0.01%	1919
2024 Q4	$312K	Sell	10,893 -678	-6%	-$23.2K	﹤0.01%	1987
2024 Q3	$437K	Sell	11,571 -1,662	-13%	-$58.3K	﹤0.01%	1931
2024 Q2	$418K	Buy	+13,233	New	+$459K	﹤0.01%	1912

Other funds holding CGON

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State of Wisconsin Investment Board's CGON Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its CG Oncology (CGON) stake by 1.8% in Q1 2026, selling an estimated $27.5K and leaving 26,840 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

State of Wisconsin Investment Board first reported a position in CGON in Q2 2024 and has held it in 8 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

State of Wisconsin Investment Board held 26,840 shares of CG Oncology worth $1.82M as of Q1 2026.
State of Wisconsin Investment Board sold 486 CG Oncology shares in Q1 2026, an estimated $27.5K.
CG Oncology made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1436 holding.
State of Wisconsin Investment Board first reported a position in CG Oncology in Q2 2024 and has held it in 8 quarters since.
233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.